Compare OWL & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OWL | COO |
|---|---|---|
| Founded | 2020 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 15.5B |
| IPO Year | N/A | N/A |
| Metric | OWL | COO |
|---|---|---|
| Price | $16.24 | $81.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | $22.50 | ★ $85.82 |
| AVG Volume (30 Days) | ★ 15.5M | 3.3M |
| Earning Date | 10-30-2025 | 12-04-2025 |
| Dividend Yield | ★ 5.54% | N/A |
| EPS Growth | ★ 47.85 | N/A |
| EPS | 0.08 | ★ 1.87 |
| Revenue | $2,745,943,000.00 | ★ $4,092,400,000.00 |
| Revenue This Year | $18.06 | $6.66 |
| Revenue Next Year | $19.63 | $5.54 |
| P/E Ratio | $209.45 | ★ $43.53 |
| Revenue Growth | ★ 27.24 | 5.06 |
| 52 Week Low | $13.25 | $61.78 |
| 52 Week High | $26.73 | $104.47 |
| Indicator | OWL | COO |
|---|---|---|
| Relative Strength Index (RSI) | 61.77 | 72.89 |
| Support Level | $14.73 | $75.25 |
| Resistance Level | $15.19 | $78.69 |
| Average True Range (ATR) | 0.56 | 2.48 |
| MACD | 0.30 | 0.47 |
| Stochastic Oscillator | 91.80 | 55.39 |
Blue Owl Capital is one of the world's largest alternative-asset managers, $295.6 billion in total managed assets, including $183.8 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, (with $68.8 billion in total AUM and $40.2 billion in fee-earning AUM), private credit ($152.1 billion/$97.3 billion), and real estate/real assets ($74.7 billion/$46.3 billion). The firm primarily serves institutional investors (68% of AUM) and high-net-worth individuals (32%). The firm operates through more than 20 offices in the Americas, and the EMEA and Asia-Pacific regions.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.